Navigation Links
'After the Genome' tackles tough questions about medicine, miracles and morality
Date:3/20/2013

s of biotechnological advances?"

In many conferences, the papers presented will be compiled into a publication, but in this case, the book comes first. Wake Forest University and Baylor University Press have worked for nearly two years to produce a book of essays containing the scholarship of the thought leaders who will present at the conference. That book will be released April 12, the day the conference begins.

The conference will end with a debate between Wake Forest University and Baylor University, using the presentations given over the two-day event as evidence and materials for discussion. Both schools trace their debate team histories back to the 1850s and have national titles under their belts. "It should be a spirited conversation," Hyde said.

Beyond the language, biotechnology has enormous economic implications. North Carolina is third in the nation behind California and Massachusetts when it comes to the life-science industrial sector and it generates $59 billion in economic activity, according to a recent study.

The Provost's Fund, Department of Communications, Humanities Institute and the Center for Bioethics, Health and Society at Wake Forest University, along with the Provost's Fund, Baylor University Press and the Institute for Faith and Learning at Baylor University organized the event.

FAQ and additional information

Is the conference open to the public?

Logistical details

  • Please visit afterthegenome.provost.wfu.edu for detailed schedule and panelist information.
  • Unless otherwise specified, events will take place in Pugh Auditorium at Benson University Center.
  • Please contact the Wake Forest new
    '/>"/>

Contact: Stephanie Skordas
skordas@wfu.edu
336-758-3826
Wake Forest University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. 1 year after Fukushima
2. AGU: Venice hasnt stopped sinking after all
3. Black flies may have a purpose after all
4. Estrogen hormone reveals protective ability after traumatic brain injury
5. Obstructive sleep apneas damage evident after 1 month
6. Scientists read the ash from the Icelandic volcano 2 years after its eruption
7. Microbial communities shifted dramatically after Deepwater Horizon spill
8. Regenerated cells may restore vision after corneal dysfunction
9. Cinega de Santa Clara unchanged after pilot run of Yuma Desalting Plant
10. Promiscuous squid fatigued after mating
11. Ethylene of no effect - why peppers do not mature after picking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
(Date:7/7/2015)... 2015 Research and ... of the "Capacitive Fingerprint Sensors Patent Landscape" ... this date, fingerprint sensing technology is the most ... are well developed. This patent landscape focuses on ... The domain of capacitive fingerprint sensors is closely ...
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... the addition of the "Next Generation Biometrics Market ... to 2020" report to their offering. ... $24.4 Billion by 2020, at a CAGR of 17.9% ... is the leading application for the market. Safran ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... Cancer Research Center have, for the first time, induced ... achievement, the first demonstration of "hibernation on demand" in ... treat cancer and prevent injury and death from insufficient ... in essence, temporarily converting mice from warm-blooded to cold-blooded ...
... that are invisible by ordinary means of detection, according ... of Medicine in St. Louis. , The researchers demonstrated ... from the surrounding tissue by direct MRI scan--could be ... minutes after the mice were injected with the nanoparticles. ...
... the March issue of the journal Cancer Cell describes a ... to a new avenue for targeted cancer therapy. The compound, ... mouse model system and has low toxicity. The results of ... in phase I clinical trials. , Plk1 is a molecule ...
Cached Biology News:Buying Time Through Hibernation on Demand 2Buying Time Through Hibernation on Demand 3Buying Time Through Hibernation on Demand 4Buying Time Through Hibernation on Demand 5Nanoparticles offer new hope for detection and treatment 2Nanoparticles offer new hope for detection and treatment 3New drug shows promise as powerful anticancer agent 2
(Date:7/30/2015)... the globe, ISN improves the efficiency and effectiveness of contractor management systems. ISN,s online ... contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... in Dallas, TX , ISN has additional offices in Calgary ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
(Date:7/29/2015)... , July 30, 2015 ... reports results for the second quarter of 2015. ... group,s results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics ... Q2 results - Performance drivers ...
(Date:7/29/2015)... , July 29, 2015 US-Australian drug ... ) today confirmed it is committed to progressing its ... soon as practicable and to ensure the Company delivers ... Executive Officer, Iain Ross , said the Company ... the lead pre-clinical programs, discovery programs and academic partnerships ...
Breaking Biology Technology:ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... LONDON, September 18 London ... industry,and London-based centres of excellence in genetics research, ... management team. The new,appointments, which include Dr Barrie ... the company,s growth as the importance of pharmacogenetics ...
... , NATICK, Mass., Sept. 18 ... announced the completion of patient enrollment in the workhorse portion ... pivotal controlled trial designed to support U.S. Food and Drug ... (MHLW) approval of the platinum chromium PROMUS((R)) Element(TM) Everolimus-Eluting Coronary ...
... , SEATTLE, Sept. 18 Omeros Corporation ... 6.82 million shares of its common stock. Omeros is ... products focused on inflammation and disorders of the central nervous ... for the initial public offering is $10.00 to $12.00 per ...
Cached Biology Technology:New Appointments at London Genetics to Drive Strategy Forward 2New Appointments at London Genetics to Drive Strategy Forward 3New Appointments at London Genetics to Drive Strategy Forward 4Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent 2Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent 3Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent 4Omeros Commences Initial Public Offering of Common Stock 2Omeros Commences Initial Public Offering of Common Stock 3
... enables sensitive, fast and specific detection of ... Short hybridisation time ( ... spreads Multiplex capability Available with ... Probes available with different labels. ...
... is a K-12 strain ideally suited as ... high transformation efficiency, blue/white screening capability (with ... result in high yields of excellent quality ... is potentially useful as a stringent host ...
... kit contains all the reagents required for ... c reductase activity in cell and tissue ... (ER)]. It has been tested on samples ... kidney, brain, spleen, and heart muscle from ...
... is an automated, confocal, real-time, single cell ... been integrated into a single, compact unit. ... provide high-resolution, automated confocal imaging with sophisticated ... cell-based assays. The system allows the user ...
Biology Products: